Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks to Watch today: TCS, Tata Steel, GMR Airports, M&M, SBI, HFCL & more
Stocks to watch today: TCS, SBI, Tata Steel, GMR Airports, M&M, HFCL, RIL, Fortis Healthcare, JSW Infra, Swiggy, Pidilite, Shree Cement, among others, will be in focus today
Pulse of the Street: Realty and healthcare lifts markets, but weak rupee clouds rally
Markets rose nearly 1% this week as softer crude oil prices, easing volatility and buying in real estate, healthcare and consumption stocks lifted sentiment. However, weakness in capital goods and power, along with continued pressure on the rupee, showed that the recovery remained selective
Stock Alert: Mphasis, RailTel Corp, Ramco Systems, Texmaco Rail, Aster DM Healthcare
RailTel Corporation has secured a Rs 16.20 crore contract from the Haryana State Electronics Development Corporation for the management of the Haryana State Wide Area Network (HSWAN).
Kotak Institutional removes ABB India, Siemens, Cummins India from model portfolio
Kotak Institutional Equities' Sanjeev Prasad prefers private banks over IT and expensive industrial stocks, citing attractive valuations, stable credit growth and the potential for re-rating. He warned that AI-driven pricing pressure makes it difficult to value IT companies and said investors should avoid chasing richly valued capital goods and electrification stocks despite strong long-term themes. Healthcare, hospitality, retail and telecom remain among his preferred sectors.
Cupid shares gain 2% as firm raises FY27 guidance, expects Q1 revenue to top Rs 150 crore
Cupid shares gained 2% as the company anticipates a record Q1 FY27 revenue exceeding Rs 150 crore. Buoyed by strong market visibility, Cupid has boosted its FY27 revenue forecast to over Rs 660 crore. This optimistic outlook is fueled by diversified business, expanding global opportunities in healthcare, and growth in its condom and lubricant portfolios. The company is also making strides in its IVD business, signaling robust future potential.
Relaxo Footwears Ltd leads gainers in 'A' group
Motherson Sumi Wiring India Ltd, Aegis Logistics Ltd, HFCL Ltd and Max Healthcare Institute Ltd are among the other gainers in the BSE's 'A' group today, 25 June 2026.
Stock Market LIVE Updates, Sensex Today: Sensex Jumps 500 Points Higher As Oil Slips To Pre-Iran War Levels - NDTV
Stock Market LIVE Updates, Sensex Today: Sensex Jumps 500 Points Higher As Oil Slips To Pre-Iran War LevelsNDTVSensex Today | Stock Market Live: Nifty at 24,200, Sensex up 550 pts; IndiGo, Max Healthcare, Maruti Suzuki top gainersMoneycontrol.comStock Market Today Live, June 25: Nifty holds above 24,100, Sensex rises 500 pts led by auto, healthcare stocksBusinessLine
Ahead of Market: 10 things that will decide stock market action on Tuesday
Indian markets ended higher on Monday, snapping Friday's pause in momentum. Investors will track US-Iran developments, technical levels, sectoral trends, weekly expiry volatility and key stock-specific action on Tuesday. Banking, utilities and healthcare stocks remained supportive, while broader market sentiment stayed positive despite monsoon-related concerns.
Metropolis Healthcare Ltd leads losers in 'A' group
Aadhar Housing Finance Ltd, Black Box Ltd, Tata Capital Ltd and Craftsman Automation Ltd are among the other losers in the BSE's 'A' group today, 22 June 2026.
Manipal Health leases Bengaluru hospital asset on nearly 30-year pact
Manipal Health Enterprises has secured a large hospital building in Bengaluru on a long-term lease. The deal spans almost 30 years, with a total rental commitment of around Rs 500 crore. This expansion follows recent acquisitions and property deals. The company is growing its network to meet rising healthcare demand.
Aegis Logistics Ltd leads gainers in 'A' group
Blue Jet Healthcare Ltd, Wockhardt Ltd, DOMS Industries Ltd and Apar Industries Ltd are among the other gainers in the BSE's 'A' group today, 11 June 2026.
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplash
Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic demand and positive global healthcare trends. Analysts see long-term growth potential from aging populations and innovation. Emerging opportunities from supply chain diversification away from China also present a positive outlook for Indian pharmaceutical companies.